Starling Oncology Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Starling Oncology Inc., formerly known as The Oncology Institute Inc., is based in CERRITOS, Calif.
| Revenue (Most Recent Fiscal Year) | $502.73M |
| Net Income (Most Recent Fiscal Year) | $-60.61M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.17 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -6.18% |
| Net Margin (Trailing 12 Months) | -6.18% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -21.51% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.36 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.15 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 24.74 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.08 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.54 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.30 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Common Shares Outstanding | 98.84M |
| Free Float | 94.49M |
| Market Capitalization | $687.92M |
| Average Volume (Last 20 Days) | 1.16M |
| Beta (Past 60 Months) | 0.41 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 36.86% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |